Diagnostic impact of exome sequencing in haemophagocytic lymphohistiocytosis: A report from the Italian reference centre

Documenti analoghi

• Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high‐risk Langerhans cell histiocytosis
  di: Linda Beneforti, et al.
  Pubblicazione: (2024)
• Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis
  di: Katarina Zivkovic, et al.
  Pubblicazione: (2025)
• Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis
  di: Samuel A. Merrill, et al.
  Pubblicazione: (2024)
• Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib
  di: Irene Trambusti, et al.
  Pubblicazione: (2024)
• Clinical and radiological spectrum of central nervous system restricted haemophagocytic lymphohistiocytosis
  di: Maha Zakariya Mohammed, et al.
  Pubblicazione: (2025)